Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 D...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 26, 2024

Disneyland Resort Celebrates Return of Pixar Fest for a Limited Time, April 26-Aug. 4, 2024 • C2N Diagnostics Expands Into Japan Through Mediford Corporation Partnership With Precivity™ Blood Testing for Alzheimer&rs • Carbon Removal and Mariculture Legislation Moves Forward in California Assembly • Brothers to Host Grand Opening Event for JDog Junk Removal & Hauling Business on April 28th • United Imaging Healthcare Releases 2023 ESG Report, Advancing Mission of Equal Healthcare for All™ • United Imaging Healthcare releases 2023 annual report, with revenue growth of 23.52% • Chase Opens Innovative Branch in Bronx’s Grand Concourse Neighborhood • BeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability Report • Harbor Point at Centerville Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third • Emmy-winning Cyberchase Expands Digital Presence to Engage Every Kid, Everywhere Ahead of Season 15 Premiere • LENNAR NOW SELLING THREE NEW-HOME COLLECTIONS AT JUNIPERS, SAN DIEGO'S RESORT-STYLE COMMUNITY FOR ACTIVE ADULTS AGED 55 AND BETT • The Sallie Mae Fund Grants $75,000 to DC College Access Program to Support Higher Education Access and Completion • Suzano 2023 annual report on Form 20-F • Crescent Point at Niantic Assisted Living Community Named One of the Country's Best by U.S. News & World Report for Third St • Dual Enrollment Helps High School Students Launch Rewarding Careers • Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions • Cabot Park Village Senior Living Community Named One of the Country's Best by U.S. News & World Report • Coastal Carolina, Southwestern Law School, and Other Institutions Streamline Accessibility Workflows With YuJa's PDF Remediation • Chestnut Park at Cleveland Circle Assisted Living Community Named One of the Country's Best by U.S. News & World Report • 29 London Partners With US Media Company Bobi Media to Strengthen Market Offering

Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2023 Dividend

FOSTER CITY, Calif. , February 02 /Businesswire/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.7% in the company’s quarterly cash dividend, beginning in the first quarter of 2023. The increase will result in a quarterly dividend of $0.75 per share of common stock. The dividend is payable on March 30, 2023, to stockholders of record at the close of business on March 15, 2023. Future dividends will be subject to Board approval.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.